Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Antiemetic Drugs market report explains the definition, types, applications, major countries, and major players of the Antiemetic Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Eisai
Eli Lilly
Takeda Pharmaceutical
Novartis
Cipla
GlaxoSmithKline
IPCA Laboratories
Johnson & Johnson
Helsinn Healthcare
Heron Therapeutics
Bristol-Myers Squibb
Pfizer
Sanofi
Sun Pharmaceutical Industries
Lupin
Abbott
RedHill
Glenmark
Merck
By Type:
Dopamine Antagonist
5-HT-3 Receptor Antagonist
NK1 Receptor Antagonist
Cannabinoid Receptor Antagonist
By End-User:
Chemotherapy
Gastroenteritis
Surgery
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Antiemetic Drugs Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Antiemetic Drugs Outlook to 2028- Original Forecasts
-
2.2 Antiemetic Drugs Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Antiemetic Drugs Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Antiemetic Drugs Market- Recent Developments
-
6.1 Antiemetic Drugs Market News and Developments
-
6.2 Antiemetic Drugs Market Deals Landscape
7 Antiemetic Drugs Raw Materials and Cost Structure Analysis
-
7.1 Antiemetic Drugs Key Raw Materials
-
7.2 Antiemetic Drugs Price Trend of Key Raw Materials
-
7.3 Antiemetic Drugs Key Suppliers of Raw Materials
-
7.4 Antiemetic Drugs Market Concentration Rate of Raw Materials
-
7.5 Antiemetic Drugs Cost Structure Analysis
-
7.5.1 Antiemetic Drugs Raw Materials Analysis
-
7.5.2 Antiemetic Drugs Labor Cost Analysis
-
7.5.3 Antiemetic Drugs Manufacturing Expenses Analysis
8 Global Antiemetic Drugs Import and Export Analysis (Top 10 Countries)
-
8.1 Global Antiemetic Drugs Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Antiemetic Drugs Export by Region (Top 10 Countries) (2017-2028)
9 Global Antiemetic Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Antiemetic Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Dopamine Antagonist Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 5-HT-3 Receptor Antagonist Consumption and Growth Rate (2017-2022)
-
9.1.3 Global NK1 Receptor Antagonist Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Cannabinoid Receptor Antagonist Consumption and Growth Rate (2017-2022)
-
9.2 Global Antiemetic Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Gastroenteritis Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Surgery Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Antiemetic Drugs Market Analysis and Outlook till 2022
-
10.1 Global Antiemetic Drugs Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Antiemetic Drugs Consumption (2017-2022)
-
10.2.2 Canada Antiemetic Drugs Consumption (2017-2022)
-
10.2.3 Mexico Antiemetic Drugs Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Antiemetic Drugs Consumption (2017-2022)
-
10.3.2 UK Antiemetic Drugs Consumption (2017-2022)
-
10.3.3 Spain Antiemetic Drugs Consumption (2017-2022)
-
10.3.4 Belgium Antiemetic Drugs Consumption (2017-2022)
-
10.3.5 France Antiemetic Drugs Consumption (2017-2022)
-
10.3.6 Italy Antiemetic Drugs Consumption (2017-2022)
-
10.3.7 Denmark Antiemetic Drugs Consumption (2017-2022)
-
10.3.8 Finland Antiemetic Drugs Consumption (2017-2022)
-
10.3.9 Norway Antiemetic Drugs Consumption (2017-2022)
-
10.3.10 Sweden Antiemetic Drugs Consumption (2017-2022)
-
10.3.11 Poland Antiemetic Drugs Consumption (2017-2022)
-
10.3.12 Russia Antiemetic Drugs Consumption (2017-2022)
-
10.3.13 Turkey Antiemetic Drugs Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Antiemetic Drugs Consumption (2017-2022)
-
10.4.2 Japan Antiemetic Drugs Consumption (2017-2022)
-
10.4.3 India Antiemetic Drugs Consumption (2017-2022)
-
10.4.4 South Korea Antiemetic Drugs Consumption (2017-2022)
-
10.4.5 Pakistan Antiemetic Drugs Consumption (2017-2022)
-
10.4.6 Bangladesh Antiemetic Drugs Consumption (2017-2022)
-
10.4.7 Indonesia Antiemetic Drugs Consumption (2017-2022)
-
10.4.8 Thailand Antiemetic Drugs Consumption (2017-2022)
-
10.4.9 Singapore Antiemetic Drugs Consumption (2017-2022)
-
10.4.10 Malaysia Antiemetic Drugs Consumption (2017-2022)
-
10.4.11 Philippines Antiemetic Drugs Consumption (2017-2022)
-
10.4.12 Vietnam Antiemetic Drugs Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Antiemetic Drugs Consumption (2017-2022)
-
10.5.2 Colombia Antiemetic Drugs Consumption (2017-2022)
-
10.5.3 Chile Antiemetic Drugs Consumption (2017-2022)
-
10.5.4 Argentina Antiemetic Drugs Consumption (2017-2022)
-
10.5.5 Venezuela Antiemetic Drugs Consumption (2017-2022)
-
10.5.6 Peru Antiemetic Drugs Consumption (2017-2022)
-
10.5.7 Puerto Rico Antiemetic Drugs Consumption (2017-2022)
-
10.5.8 Ecuador Antiemetic Drugs Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Antiemetic Drugs Consumption (2017-2022)
-
10.6.2 Kuwait Antiemetic Drugs Consumption (2017-2022)
-
10.6.3 Oman Antiemetic Drugs Consumption (2017-2022)
-
10.6.4 Qatar Antiemetic Drugs Consumption (2017-2022)
-
10.6.5 Saudi Arabia Antiemetic Drugs Consumption (2017-2022)
-
10.6.6 United Arab Emirates Antiemetic Drugs Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Antiemetic Drugs Consumption (2017-2022)
-
10.7.2 South Africa Antiemetic Drugs Consumption (2017-2022)
-
10.7.3 Egypt Antiemetic Drugs Consumption (2017-2022)
-
10.7.4 Algeria Antiemetic Drugs Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Antiemetic Drugs Consumption (2017-2022)
-
10.8.2 New Zealand Antiemetic Drugs Consumption (2017-2022)
11 Global Antiemetic Drugs Competitive Analysis
-
11.1 Eisai
-
11.1.1 Eisai Company Details
-
11.1.2 Eisai Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Eisai Antiemetic Drugs Main Business and Markets Served
-
11.1.4 Eisai Antiemetic Drugs Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Eli Lilly
-
11.2.1 Eli Lilly Company Details
-
11.2.2 Eli Lilly Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Eli Lilly Antiemetic Drugs Main Business and Markets Served
-
11.2.4 Eli Lilly Antiemetic Drugs Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Takeda Pharmaceutical
-
11.3.1 Takeda Pharmaceutical Company Details
-
11.3.2 Takeda Pharmaceutical Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Takeda Pharmaceutical Antiemetic Drugs Main Business and Markets Served
-
11.3.4 Takeda Pharmaceutical Antiemetic Drugs Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Novartis
-
11.4.1 Novartis Company Details
-
11.4.2 Novartis Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Novartis Antiemetic Drugs Main Business and Markets Served
-
11.4.4 Novartis Antiemetic Drugs Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Cipla
-
11.5.1 Cipla Company Details
-
11.5.2 Cipla Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Cipla Antiemetic Drugs Main Business and Markets Served
-
11.5.4 Cipla Antiemetic Drugs Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 GlaxoSmithKline
-
11.6.1 GlaxoSmithKline Company Details
-
11.6.2 GlaxoSmithKline Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 GlaxoSmithKline Antiemetic Drugs Main Business and Markets Served
-
11.6.4 GlaxoSmithKline Antiemetic Drugs Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 IPCA Laboratories
-
11.7.1 IPCA Laboratories Company Details
-
11.7.2 IPCA Laboratories Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 IPCA Laboratories Antiemetic Drugs Main Business and Markets Served
-
11.7.4 IPCA Laboratories Antiemetic Drugs Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Johnson & Johnson
-
11.8.1 Johnson & Johnson Company Details
-
11.8.2 Johnson & Johnson Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Johnson & Johnson Antiemetic Drugs Main Business and Markets Served
-
11.8.4 Johnson & Johnson Antiemetic Drugs Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Helsinn Healthcare
-
11.9.1 Helsinn Healthcare Company Details
-
11.9.2 Helsinn Healthcare Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Helsinn Healthcare Antiemetic Drugs Main Business and Markets Served
-
11.9.4 Helsinn Healthcare Antiemetic Drugs Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Heron Therapeutics
-
11.10.1 Heron Therapeutics Company Details
-
11.10.2 Heron Therapeutics Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Heron Therapeutics Antiemetic Drugs Main Business and Markets Served
-
11.10.4 Heron Therapeutics Antiemetic Drugs Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Bristol-Myers Squibb
-
11.11.1 Bristol-Myers Squibb Company Details
-
11.11.2 Bristol-Myers Squibb Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Bristol-Myers Squibb Antiemetic Drugs Main Business and Markets Served
-
11.11.4 Bristol-Myers Squibb Antiemetic Drugs Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Pfizer
-
11.12.1 Pfizer Company Details
-
11.12.2 Pfizer Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Pfizer Antiemetic Drugs Main Business and Markets Served
-
11.12.4 Pfizer Antiemetic Drugs Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Sanofi
-
11.13.1 Sanofi Company Details
-
11.13.2 Sanofi Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Sanofi Antiemetic Drugs Main Business and Markets Served
-
11.13.4 Sanofi Antiemetic Drugs Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Sun Pharmaceutical Industries
-
11.14.1 Sun Pharmaceutical Industries Company Details
-
11.14.2 Sun Pharmaceutical Industries Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Sun Pharmaceutical Industries Antiemetic Drugs Main Business and Markets Served
-
11.14.4 Sun Pharmaceutical Industries Antiemetic Drugs Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Lupin
-
11.15.1 Lupin Company Details
-
11.15.2 Lupin Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Lupin Antiemetic Drugs Main Business and Markets Served
-
11.15.4 Lupin Antiemetic Drugs Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Abbott
-
11.16.1 Abbott Company Details
-
11.16.2 Abbott Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Abbott Antiemetic Drugs Main Business and Markets Served
-
11.16.4 Abbott Antiemetic Drugs Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 RedHill
-
11.17.1 RedHill Company Details
-
11.17.2 RedHill Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 RedHill Antiemetic Drugs Main Business and Markets Served
-
11.17.4 RedHill Antiemetic Drugs Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Glenmark
-
11.18.1 Glenmark Company Details
-
11.18.2 Glenmark Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Glenmark Antiemetic Drugs Main Business and Markets Served
-
11.18.4 Glenmark Antiemetic Drugs Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Merck
-
11.19.1 Merck Company Details
-
11.19.2 Merck Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Merck Antiemetic Drugs Main Business and Markets Served
-
11.19.4 Merck Antiemetic Drugs Product Portfolio
-
11.19.5 Recent Research and Development Strategies
12 Global Antiemetic Drugs Market Outlook by Types and Applications to 2028
-
12.1 Global Antiemetic Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Dopamine Antagonist Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global 5-HT-3 Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global NK1 Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Cannabinoid Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Antiemetic Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Gastroenteritis Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Surgery Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Antiemetic Drugs Market Analysis and Outlook to 2028
-
13.1 Global Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.2.2 Canada Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.2.3 Mexico Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.3.2 UK Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.3.3 Spain Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.3.4 Belgium Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.3.5 France Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.3.6 Italy Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.3.7 Denmark Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.3.8 Finland Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.3.9 Norway Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.3.10 Sweden Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.3.11 Poland Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.3.12 Russia Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.3.13 Turkey Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.4.2 Japan Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.4.3 India Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.4.4 South Korea Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.4.8 Thailand Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.4.9 Singapore Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.4.11 Philippines Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.5.2 Colombia Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.5.3 Chile Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.5.4 Argentina Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.5.6 Peru Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.6.3 Oman Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.6.4 Qatar Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.7.2 South Africa Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.7.3 Egypt Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.7.4 Algeria Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Antiemetic Drugs Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Antiemetic Drugs Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Antiemetic Drugs
-
Figure of Antiemetic Drugs Picture
-
Table Global Antiemetic Drugs Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Antiemetic Drugs Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Dopamine Antagonist Consumption and Growth Rate (2017-2022)
-
Figure Global 5-HT-3 Receptor Antagonist Consumption and Growth Rate (2017-2022)
-
Figure Global NK1 Receptor Antagonist Consumption and Growth Rate (2017-2022)
-
Figure Global Cannabinoid Receptor Antagonist Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Gastroenteritis Consumption and Growth Rate (2017-2022)
-
Figure Global Surgery Consumption and Growth Rate (2017-2022)
-
Figure Global Antiemetic Drugs Consumption by Country (2017-2022)
-
Table North America Antiemetic Drugs Consumption by Country (2017-2022)
-
Figure United States Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Canada Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Mexico Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Antiemetic Drugs Consumption by Country (2017-2022)
-
Figure Germany Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure UK Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Spain Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Belgium Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure France Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Italy Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Denmark Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Finland Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Norway Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Sweden Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Poland Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Russia Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Turkey Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Table APAC Antiemetic Drugs Consumption by Country (2017-2022)
-
Figure China Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Thailand Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Singapore Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Philippines Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Table South America Antiemetic Drugs Consumption by Country (2017-2022)
-
Figure Brazil Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Colombia Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Chile Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Argentina Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Peru Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Table GCC Antiemetic Drugs Consumption by Country (2017-2022)
-
Figure Bahrain Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Oman Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Qatar Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Table Africa Antiemetic Drugs Consumption by Country (2017-2022)
-
Figure Nigeria Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Africa Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Egypt Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Algeria Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Table Oceania Antiemetic Drugs Consumption by Country (2017-2022)
-
Figure Australia Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Table Eisai Company Details
-
Table Eisai Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai Antiemetic Drugs Main Business and Markets Served
-
Table Eisai Antiemetic Drugs Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Antiemetic Drugs Main Business and Markets Served
-
Table Eli Lilly Antiemetic Drugs Product Portfolio
-
Table Takeda Pharmaceutical Company Details
-
Table Takeda Pharmaceutical Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Antiemetic Drugs Main Business and Markets Served
-
Table Takeda Pharmaceutical Antiemetic Drugs Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Antiemetic Drugs Main Business and Markets Served
-
Table Novartis Antiemetic Drugs Product Portfolio
-
Table Cipla Company Details
-
Table Cipla Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Antiemetic Drugs Main Business and Markets Served
-
Table Cipla Antiemetic Drugs Product Portfolio
-
Table GlaxoSmithKline Company Details
-
Table GlaxoSmithKline Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Antiemetic Drugs Main Business and Markets Served
-
Table GlaxoSmithKline Antiemetic Drugs Product Portfolio
-
Table IPCA Laboratories Company Details
-
Table IPCA Laboratories Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table IPCA Laboratories Antiemetic Drugs Main Business and Markets Served
-
Table IPCA Laboratories Antiemetic Drugs Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Antiemetic Drugs Main Business and Markets Served
-
Table Johnson & Johnson Antiemetic Drugs Product Portfolio
-
Table Helsinn Healthcare Company Details
-
Table Helsinn Healthcare Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Helsinn Healthcare Antiemetic Drugs Main Business and Markets Served
-
Table Helsinn Healthcare Antiemetic Drugs Product Portfolio
-
Table Heron Therapeutics Company Details
-
Table Heron Therapeutics Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Heron Therapeutics Antiemetic Drugs Main Business and Markets Served
-
Table Heron Therapeutics Antiemetic Drugs Product Portfolio
-
Table Bristol-Myers Squibb Company Details
-
Table Bristol-Myers Squibb Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Antiemetic Drugs Main Business and Markets Served
-
Table Bristol-Myers Squibb Antiemetic Drugs Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Antiemetic Drugs Main Business and Markets Served
-
Table Pfizer Antiemetic Drugs Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Antiemetic Drugs Main Business and Markets Served
-
Table Sanofi Antiemetic Drugs Product Portfolio
-
Table Sun Pharmaceutical Industries Company Details
-
Table Sun Pharmaceutical Industries Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Industries Antiemetic Drugs Main Business and Markets Served
-
Table Sun Pharmaceutical Industries Antiemetic Drugs Product Portfolio
-
Table Lupin Company Details
-
Table Lupin Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lupin Antiemetic Drugs Main Business and Markets Served
-
Table Lupin Antiemetic Drugs Product Portfolio
-
Table Abbott Company Details
-
Table Abbott Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Antiemetic Drugs Main Business and Markets Served
-
Table Abbott Antiemetic Drugs Product Portfolio
-
Table RedHill Company Details
-
Table RedHill Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table RedHill Antiemetic Drugs Main Business and Markets Served
-
Table RedHill Antiemetic Drugs Product Portfolio
-
Table Glenmark Company Details
-
Table Glenmark Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Glenmark Antiemetic Drugs Main Business and Markets Served
-
Table Glenmark Antiemetic Drugs Product Portfolio
-
Table Merck Company Details
-
Table Merck Antiemetic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Antiemetic Drugs Main Business and Markets Served
-
Table Merck Antiemetic Drugs Product Portfolio
-
Figure Global Dopamine Antagonist Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 5-HT-3 Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NK1 Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cannabinoid Receptor Antagonist Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastroenteritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antiemetic Drugs Consumption Forecast by Country (2022-2028)
-
Table North America Antiemetic Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Antiemetic Drugs Consumption Forecast by Country (2022-2028)
-
Figure Germany Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Antiemetic Drugs Consumption Forecast by Country (2022-2028)
-
Figure China Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Antiemetic Drugs Consumption Forecast by Country (2022-2028)
-
Figure Brazil Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Antiemetic Drugs Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Antiemetic Drugs Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Antiemetic Drugs Consumption Forecast by Country (2022-2028)
-
Figure Australia Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
